{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:45Z","timestamp":1790381265438,"version":"4.1.0"},"reference-count":41,"publisher":"Centers for Disease Control MMWR Office","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7102a1","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:02:50Z","timestamp":1664463770000},"page":"1-8","source":"Crossref","is-referenced-by-count":21,"title":["Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Jennifer P.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace D.","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo J.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Gutelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R1","unstructured":"Food and Drug Administration. FDA news release: FDA approves vaccine to prevent cholera for travelers. Silver Spring, MD, US Department of Health and Human Services, Food and Drug Administration; 2016. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-vaccine-prevent-cholera-travelers"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.15585\/mmwr.mm6618a6","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of cholera vaccine.","volume":"66","author":"Wong","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R3","unstructured":"Food and Drug Administration. Supplemental approval. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. https:\/\/www.fda.gov\/media\/144754\/download"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R4","unstructured":"CDC. Cholera\u2014Vibrio cholerae infection. Illness and symptoms. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/cholera\/illness.html"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R5","unstructured":"World Health Organization. Cholera. Geneva, Switzerland: World Health Organization; 2022. https:\/\/www.who.int\/health-topics\/cholera#tab=tab_1"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R6","unstructured":"Global Task Force on Cholera Control. Cholera outbreak response field manual. Geneva, Switzerland: World Health Organization, Global Task Force on Cholera Control; 2019. https:\/\/www.gtfcc.org\/wp-content\/uploads\/2020\/05\/gtfcc-cholera-outbreak-response-field-manual.pdf"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R7","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries.","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/S0950268814001186","article-title":"Cholera in the United States, 2001-2011: a reflection of patterns of global epidemiology and travel.","volume":"143","author":"Loharikar","year":"2015","journal-title":"Epidemiol Infect"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R9","unstructured":"Collins J, editor. Background on cholera and CVD 103-HgR. Advisory Committee on Immunization Practices February 25, 2021 meeting. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-02\/24-25\/02-Cholera-Collins.pdf"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R10","unstructured":"CDC. Travelers\u2019 health. Cholera. Atlanta GA: US Department of Health and Human Services, CDC; 2022. https:\/\/wwwnc.cdc.gov\/travel\/diseases\/cholera"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1708-8305.2012.00607.x","article-title":"A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010.","volume":"19","author":"Haus-Cheymol","year":"2012","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jtm.12075","article-title":"Diarrheal illness among US residents providing medical services in Haiti during the cholera epidemic, 2010 to 2011.","volume":"21","author":"Schilling","year":"2014","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/clinids\/22.6.1108","article-title":"Cholera among Americans living in Peru.","volume":"22","author":"Taylor","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114050","article-title":"Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.","volume":"121","author":"Glass","year":"1985","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1537-2995.2004.03338.x","article-title":"ABO and Rh(D) phenotype frequencies of different racial\/ethnic groups in the United States.","volume":"44","author":"Garratty","year":"2004","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R17","doi-asserted-by":"publisher","first-page":"e0132920","DOI":"10.1371\/journal.pone.0132920","article-title":"Cholera in pregnancy: a systematic review and meta-analysis of fetal, neonatal, and maternal mortality.","volume":"10","author":"Tran","year":"2015","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R19","unstructured":"World Health Organization. Prequalified vaccines. Geneva, Switzerland; 2022. https:\/\/extranet.who.int\/pqweb\/vaccines\/prequalified-vaccines?field_vaccines_effective_date%5Bdate%5D=&field_vaccines_effective_date_1%5Bdate%5D=&field_vaccines_type%5B%5D=cholera%3A+inactivated+oral&field_vaccines_name=&search_api_views_fulltext=&field_vaccines_number_of_doses="},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R20","doi-asserted-by":"publisher","first-page":"S732","DOI":"10.1093\/infdis\/jiab497","article-title":"Correlates of protection for cholera.","volume":"224","author":"Iyer","year":"2021","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/infdis\/jir416","article-title":"Natural cholera infection-derived immunity in an endemic setting.","volume":"204","author":"Ali","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","article-title":"Duration of infection-derived immunity to cholera.","volume":"143","author":"Levine","year":"1981","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R23","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R24","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1128\/CVI.00321-12","article-title":"Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.","volume":"19","author":"Johnson","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R25","doi-asserted-by":"publisher","first-page":"e0006399","DOI":"10.1371\/journal.pntd.0006399","article-title":"Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.","volume":"12","author":"Aktar","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R26","unstructured":"Ahmed FU. US Advisory Committee on Immunization Practices (ACIP) handbook for handbook for developing evidence-based recommendations, Version 1.2. Atlanta GA: US Department of Health and Human Services, CDC; 2013. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/downloads\/handbook.pdf"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4269\/ajtmh.20-0917","article-title":"Safety and immunogenicity of live oral cholera vaccine CVD 103-HgR in children aged 2\u20135 years in the United States.","volume":"104","author":"McCarty","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4269\/ajtmh.20-1576","article-title":"Long-term immunogenicity of live oral cholera vaccine CVD 103-HgR in adolescents aged 12\u201317 years in the United States.","volume":"104","author":"McCarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.19-0241","article-title":"Safety and immunogenicity of live oral cholera vaccine CVD 103-HgR in children and adolescents aged 6\u201317 years.","volume":"102","author":"McCarty","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.vaccine.2019.01.077","article-title":"Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.","volume":"37","author":"McCarty","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.vaccine.2017.12.062","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.","volume":"36","author":"McCarty","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor.","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R33","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.15585\/mmwr.mm6745a4","article-title":"Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices.","volume":"67","author":"Lee","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R34","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R35","unstructured":"VAXCHORA [Package insert]. Emergent BioSolutions, Gaithersburg, MD; 2022. https:\/\/www.fda.gov\/media\/128415\/download"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R36","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1128\/iai.64.4.1454-1457.1996","article-title":"Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.","volume":"64","author":"Kollaritsch","year":"1996","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R37","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1128\/iai.60.9.3916-3917.1992","article-title":"Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.","volume":"60","author":"Cryz","year":"1992","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R38","unstructured":"McCarty J, editor. Vaxchora vaccine\u2014pediatric dose development. Advisory Committee on Immunization Practices January 12, 2022, meeting. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-01-12\/02-Cholera-McCarty-508.pdf"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R39","unstructured":"McCarty J, editor. Vaxchora in children and adolescents. Advisory Committee on Immunization Practices February 24\u201325, 2021, meeting. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-02\/24-25\/03-Cholera-McCarty.pdf"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R40","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.","volume":"76","author":"Perry","year":"1998","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.rr7102a1-202209291100-R41","unstructured":"CDC. Handwashing in communities: clean hands save lives. When and how to wash your hands. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https:\/\/www.cdc.gov\/handwashing\/when-how-handwashing.html"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:02:57Z","timestamp":1664463777000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/rr\/rr7102a1.htm?s_cid=rr7102a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7102a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,30]]},"published":{"date-parts":[[2022,9,30]]}}}